Professor Stricker and his fellow, James Thomspon, were invited by The Lancet to comment on the recently published article, “The Diagnostic Accuracy of Multiparametric MRI and Transrectal Biopsy in Prostate Cancer”.
The comment was published on the 23rd of January2017.
Stricker and Thomspon commented that the imaging study did demonstrate that multiparametric MRI of the prostate improved detection of aggressive tumours whislt excluding the detection of insignificant tumours. This is an improvement in the diagnostic pathway over existing methods: PSA testing and digital rectal examination and subsequent transrectal biopsy. Stricker and Thompson concluded that the use of MRI and biological genetic tools to select patients for biopsy and treatment would help, ‘ … reduce over-detection, over-treatment and under-treatment, thus improving oncologic, quality of life, and cost-efficiency outcomes for the population’
Professor Stricker was one of the first to pioneer the work of MRI in the prostate and this work was published in The Journal of Urology in 2016.